This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Partridge EA, Davey MG, Hornick MA, McGovern PE, Mejaddam AY, Vrecenak JD, et al. An extra-uterine system to physiologically support the extreme premature lamb. Nat Commun. 2017;8:15112. https://doi.org/10.1038/ncomms15112. Erratum in: Nat Commun. 8:15794.
Romanis EC. Artificial womb technology and the significance of birth: why gestatelings are not newborns (or fetuses). J Med Ethics. 2019;45:728–31. https://doi.org/10.1136/medethics-2019-105723.
De Bie FR, Kim SD, Bose SK, Nathanson P, Partridge EA, Flake AW, et al. Ethics considerations regarding artificial womb technology for the fetonate. Am J Bioeth. 2023;23:67–78. https://doi.org/10.1080/15265161.2022.2048738.
Werner KM, Mercurio MR. Ethical considerations in the use of artificial womb/placenta technology. Semin Perinatol. 2022;46:151521. https://doi.org/10.1016/j.semperi.2021.151521.
NICHD Extremely Preterm Birth Outcomes Tool. https://www.nichd.nih.gov/research/supported/EPBO/use. Accessed May 2023.
Kukora SK, Mychaliska G, Weiss EM. Ethical challenges in first-in-human trials of the artificial placenta and artificial womb: not all technologies are created equally, ethically. J Perinatol. 2023. https://doi.org/10.1038/s41372-023-01713-5. Epub ahead of print.
Flake AW, De Bie FR, Munson DA, Feudtner C. The artificial placenta and EXTEND technologies: one of these things is not like the other. J Perinatol. 2023. https://doi.org/10.1038/s41372-023-01716-2. Epub ahead of print.
Mike V, Krauss AN, Ross GS. Neonatal extracorporeal membrane oxygenation (ECMO): clinical trials and the ethics of evidence. J Med Ethics. 1993;19:212–8. https://doi.org/10.1136/jme.19.4.212.
Bell EF, Hintz SR, Hansen NI, Bann CM, Wyckoff MH, DeMauro SB, et al. Mortality, in-hospital morbidity, care practices, and 2-year outcomes for extremely preterm infants in the US, 2013–2018. JAMA. 2022;327:248–63. https://doi.org/10.1001/jama.2021.23580. Erratum in: JAMA. 2022;327:2151.
Watkins PL, Dagle JM, Bell EF, Colaizy TT. Outcomes at 18 to 22 months of corrected age for infants born at 22 to 25 weeks of gestation in a center practicing active management. J Pediatr. 2020;217:52–58.e1. https://doi.org/10.1016/j.jpeds.2019.08.028.
Yanagisawa T, Nakamura T, Kokubo M. Prognosis of 22- and 23-gestational-week-old infants at our facility: a retrospective cohort study. Am J Perinatol. 2022. https://doi.org/10.1055/a-1779-4032. Epub ahead of print.
Author information
Authors and Affiliations
Contributions
KMW, ACB, MRM contributed to the theory, writing, editing, and final approval of this manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Werner, K.M., Baker, A.C. & Mercurio, M.R. Unique ethical considerations of the artificial womb and placenta: the threshold for patient eligibility in clinical trials. J Perinatol 43, 1335–1336 (2023). https://doi.org/10.1038/s41372-023-01753-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41372-023-01753-x